TAK - J&J reportedly in talks to buy Protagonist
2025-10-10 11:36:01 ET
More on Johnson & Johnson, Protagonist
- Johnson & Johnson: A Safe Haven That's Quietly Becoming A Bit Overpriced
- Johnson & Johnson (JNJ) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript
- Protagonist Therapeutics, Inc. (PTGX) Presents At H.C. Wainwright 27th Annual Global Investment Conference Transcript
- Legend Biotech, J&J ink Carvykti supply agreement
- J&J hit with $966M jury award in Los Angeles over talc-related cancer case